Long-term management of alopecia areata with JAK inhibitors

Alopecia areata pathophysiology

Episode 4. “We don’t understand that initial inciting event that causes alopecia areata. Patients come into the clinic fixated on the ‘why,’ which is still not well understood.” Dermatologist Brittany Craiglow discusses advances in our understanding of AA pathogenesis, including the role of the JAK–STAT pathway and potential treatment targets.

Long-term management of alopecia areata with JAK inhibitors

Episode 3. “[JAK inhibitors] can be really life-changing for patients.” Dermatologist Leila Asfour discusses the nuances of Janus kinase (JAK) inhibitors in long-term AA management.

Treatment choice, shared decision-making, and treatment planning

Episode 2. “[People with AA] want to talk to someone who not only understands the condition medically but the impact that it’s going to have on the individual, and present them with ways forward.” Patient advocate Damien Hamber and dermatologist Brittany Craiglow discuss the importance of treatment selection and planning, alongside active collaboration, in effective clinical management of AA.

Unmet needs in the management of alopecia areata

Episode 1. “The most important things that I can do is acknowledge the experience and normalize that this is hard.” Dermatologist Brittany Craiglow and patient advocate Damien Hamber discuss unmet needs in AA management and their impact on patients.